The Scientist

» extinction, disease/medicine and culture

Most Recent

image: Notable Science Quotes

Notable Science Quotes

By | January 1, 2017

Science under Trump, gene drive, medical marijuana, and more

0 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

image: Cheetah Range Drops 90 Percent

Cheetah Range Drops 90 Percent

By | December 27, 2016

Estimating only 7,100 individuals remaining, researchers urge a reclassification of the species from vulnerable to endangered.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Speaking of Science: 2016

Speaking of Science: 2016

By | December 19, 2016

Selected quotes from an eventful year

0 Comments

image: IUCN Declares Giraffes Vulnerable to Extinction

IUCN Declares Giraffes Vulnerable to Extinction

By | December 9, 2016

The iconic mammals have been declining in number for decades and could face extinction if conservation measures are not enacted.

0 Comments

image: Trumping Science: Part II

Trumping Science: Part II

By | December 6, 2016

As Inauguration Day nears, scientists and science advocates are voicing their unease with the Trump Administration’s potential effects on research.

2 Comments

image: Book Excerpt from <em>Redesigning Life</em>

Book Excerpt from Redesigning Life

By | December 1, 2016

In Chapter 8, author John Parrington explores the intersection of precision genome editing and stem cell technologies.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | December 1, 2016

The importance of science innovation, publishing and gender, and more

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS